Suvretta Capital Management 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Suvretta Capital Management disclosed 99 US equity positions worth $2.5bn in its Q1 2025 13F filing. The largest position was ARQT at 7.2% of the reported book, followed by BHVN and BENITEC BIOPHARMA INC. Against the Q4 2024 filing, it opened 9 new positions, added to 20 and reduced 12 among the top 50 holdings.
What did Suvretta Capital Management own in Q1 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 7.2% | $178.7m | 11,422,978 | 0% | held |
| 2 | BHVN BIOHAVEN LTD | Healthcare | 5.5% | $135.1m | 5,620,271 | 0% | held |
| 3 | BENITEC BIOPHARMA INC | 5.2% | $128.5m | 9,876,506 | 10% | added | |
| 4 | LEGN LEGEND BIOTECH CORP | Healthcare | 5.1% | $127.2m | 3,749,965 | 7% | added |
| 5 | INSM INSMED INC | Healthcare | 4.6% | $113.9m | 1,492,383 | -7% | reduced |
| 6 | 89BIO INC | 4.2% | $104.2m | 14,335,244 | 41% | added | |
| 7 | META META PLATFORMS INC | Communication Services | 4.2% | $103.6m | 179,664 | 5% | added |
| 8 | INTRA-CELLULAR THERAPIES INC | 3.7% | $92.5m | 700,904 | -51% | reduced | |
| 9 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 3.0% | $73.3m | 2,024,500 | 76% | added |
| 10 | MSFT MICROSOFT CORP | Technology | 2.7% | $67.6m | 180,125 | 52% | added |
| 11 | AMZN AMAZON COM INC | Consumer Cyclical | 2.7% | $67.4m | 354,356 | 1% | added |
| 12 | TSM TAIWAN SEMICONDUCTOR MFG LTD | Technology | 2.4% | $58.2m | 350,514 | 1% | added |
| 13 | 4XC1 KALVISTA PHARMACEUTICALS INC | 2.3% | $56.7m | 4,913,012 | 0% | held | |
| 14 | APO APOLLO GLOBAL MGMT INC | Financial Services | 2.2% | $54.3m | 396,540 | -15% | reduced |
| 15 | KURA KURA ONCOLOGY INC | Healthcare | 2.0% | $49.1m | 7,439,259 | 47% | added |
| 16 | COF CAPITAL ONE FINL CORP | Financial Services | 1.8% | $44.0m | 245,222 | -3% | reduced |
| 17 | AVBP ARRIVENT BIOPHARMA INC | 1.7% | $43.2m | 2,337,496 | 4% | added | |
| 18 | AMD ADVANCED MICRO DEVICES INC | Technology | 1.7% | $41.5m | 404,008 | 20% | added |
| 19 | IMTX IMMATICS N.V | Healthcare | 1.7% | $41.2m | 9,135,029 | 80% | added |
| 20 | GE GE AEROSPACE | Industrials | 1.6% | $40.2m | 200,662 | 0% | held |
| 21 | NVDA NVIDIA CORPORATION | Technology | 1.5% | $38.2m | 352,765 | 95% | added |
| 22 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 1.5% | $36.9m | 6,804,091 | 0% | held |
| 23 | APELLIS PHARMACEUTICALS INC | 1.5% | $36.0m | 1,646,615 | 108% | added | |
| 24 | HD HOME DEPOT INC | Consumer Cyclical | 1.4% | $35.8m | 97,571 | – | new |
| 25 | ORCL ORACLE CORP | Technology | 1.3% | $31.6m | 226,318 | 0% | held |
| 26 | TSLA TESLA INC | Consumer Cyclical | 1.3% | $31.6m | 122,016 | -25% | reduced |
| 27 | BAC BANK AMERICA CORP | Financial Services | 1.3% | $31.5m | 753,913 | – | new |
| 28 | KO COCA COLA CO | Consumer Defensive | 1.2% | $29.8m | 415,720 | -63% | reduced |
| 29 | CMG CHIPOTLE MEXICAN GRILL INC | Consumer Cyclical | 1.1% | $27.1m | 539,540 | – | new |
| 30 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.1% | $26.5m | 1,667,759 | – | new |
| 31 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 1.1% | $26.4m | 262,099 | -34% | reduced |
| 32 | UAL UNITED AIRLS HLDGS INC | Industrials | 1.0% | $25.3m | 366,375 | 83% | added |
| 33 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 0.9% | $23.4m | 3,502,000 | 36% | added |
| 34 | FERG FERGUSON ENTERPRISES INC | Industrials | 0.8% | $20.8m | 129,924 | -47% | reduced |
| 35 | SNOW SNOWFLAKE INC | Technology | 0.8% | $20.2m | 137,886 | – | new |
| 36 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 0.8% | $20.1m | 2,560,904 | 344% | added |
| 37 | PALVELLA THERAPEUTICS INC NE | 0.8% | $20.0m | 714,463 | 0% | held | |
| 38 | DDOG DATADOG INC | Technology | 0.7% | $18.2m | 183,231 | 4% | added |
| 39 | JNJ JOHNSON & JOHNSON | Healthcare | 0.7% | $18.1m | 109,386 | -22% | reduced |
| 40 | ABEO ABEONA THERAPEUTICS INC | Healthcare | 0.7% | $17.5m | 3,685,503 | 0% | held |
| 41 | ERAS ERASCA INC | Healthcare | 0.7% | $16.9m | 12,315,004 | 0% | held |
| 42 | BIIB BIOGEN INC | Healthcare | 0.7% | $16.5m | 120,736 | 5% | added |
| 43 | CZR CAESARS ENTERTAINMENT INC NE | Consumer Cyclical | 0.7% | $16.3m | 652,493 | -16% | reduced |
| 44 | AURA AURA BIOSCIENCES INC | 0.6% | $16.0m | 2,731,886 | – | new | |
| 45 | UNH UNITEDHEALTH GROUP INC | Healthcare | 0.6% | $15.7m | 29,900 | -60% | reduced |
| 46 | TTWO TAKE-TWO INTERACTIVE SOFTWAR | Communication Services | 0.6% | $15.0m | 72,400 | – | new |
| 47 | MRNA MODERNA INC | Healthcare | 0.6% | $14.7m | 517,163 | – | new |
| 48 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 0.6% | $14.6m | 5,067,394 | 52% | added |
| 49 | GS GOLDMAN SACHS GROUP INC | Financial Services | 0.6% | $14.0m | 25,538 | -66% | reduced |
| 50 | RBLX ROBLOX CORP | Communication Services | 0.5% | $13.3m | 227,710 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.